ایزاووکونازول (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "ایزاووکونازول" in Persian language version.

refsWebsite

Global rank Persian rank

5nih.gov

4^th place

5^th place

4web.archive.org

1^st place

3doi.org

2^nd place

2funnelback.com

low place

2medicines.org.uk

3,823^rd place

1,188^th place

1drugs.com

399^th place

104^th place

1tga.gov.au

3,984^th place

1,143^rd place

1hres.ca

low place

1europa.eu

68^th place

179^th place

1books.google.com

3^rd place

6^th place

1semanticscholar.org

11^th place

52^nd place

1sagepub.com

731^st place

681^st place

books.google.com

Wilkes, Gail M.; Barton-Burke, Margaret (2019). 2020-2021 Oncology Nursing Drug Handbook. Jones & Bartlett Learning. pp. 1874–1876. ISBN 978-1-284-17132-7.

doi.org

Donnelley MA, Zhu ES, Thompson GR (2 June 2016). "Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections". Infection and Drug Resistance. 9: 79–86. doi:10.2147/IDR.S81416. PMC 4898026. PMID 27330318.
Miceli MH, Kauffman CA (November 2015). "Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent". Clinical Infectious Diseases. 61 (10): 1558–65. doi:10.1093/cid/civ571. PMID 26179012.
Pettit NN, Carver PL (July 2015). "Isavuconazole: A New Option for the Management of Invasive Fungal Infections". The Annals of Pharmacotherapy. 49 (7): 825–42. doi:10.1177/1060028015581679. PMID 25940222. S2CID 208875031. Archived from the original on 5 September 2021. Retrieved 15 July 2022.

drugs.com

"Isavuconazonium (Cresemba) Use During Pregnancy". Drugs.com. 31 January 2020. Retrieved 26 August 2020.

europa.eu

ema.europa.eu

"Cresemba EPAR". European Medicines Agency (EMA). Retrieved 26 August 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

funnelback.com

tga-search.clients.funnelback.com

"Cresemba isavuconazole (as isavuconazonium sulfate) 200 mg powder for injection vial". Therapeutic Goods Administration (TGA). ARTG ID 305480. Archived from the original on 19 June 2022. Retrieved 5 September 2021.
"Cresemba isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack". Therapeutic Goods Administration (TGA). ARTG ID 305452. Archived from the original on 5 September 2021. Retrieved 5 September 2021.

hres.ca

hpr-rps.hres.ca

"Search Page - Drug and Health Product Register". 23 October 2014.

medicines.org.uk

"Cresemba 100 mg hard capsules - Summary of Product Characteristics (SmPC)". (emc). 28 June 2021. Retrieved 5 September 2021.
"Cresemba 200mg Powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC)". (emc). 28 June 2021. Retrieved 5 September 2021.

nih.gov

sagepub.com

aop.sagepub.com

Pettit NN, Carver PL (July 2015). "Isavuconazole: A New Option for the Management of Invasive Fungal Infections". The Annals of Pharmacotherapy. 49 (7): 825–42. doi:10.1177/1060028015581679. PMID 25940222. S2CID 208875031. Archived from the original on 5 September 2021. Retrieved 15 July 2022.

semanticscholar.org

api.semanticscholar.org

Pettit NN, Carver PL (July 2015). "Isavuconazole: A New Option for the Management of Invasive Fungal Infections". The Annals of Pharmacotherapy. 49 (7): 825–42. doi:10.1177/1060028015581679. PMID 25940222. S2CID 208875031. Archived from the original on 5 September 2021. Retrieved 15 July 2022.

tga.gov.au

"AusPAR: Isavuconazole (as sulphate)". Therapeutic Goods Administration (TGA). 22 January 2020. Archived from the original on 5 September 2021. Retrieved 5 September 2021.

web.archive.org

"Cresemba isavuconazole (as isavuconazonium sulfate) 200 mg powder for injection vial". Therapeutic Goods Administration (TGA). ARTG ID 305480. Archived from the original on 19 June 2022. Retrieved 5 September 2021.
"Cresemba isavuconazole (as isavuconazonium sulfate) 100 mg capsule blister pack". Therapeutic Goods Administration (TGA). ARTG ID 305452. Archived from the original on 5 September 2021. Retrieved 5 September 2021.
"AusPAR: Isavuconazole (as sulphate)". Therapeutic Goods Administration (TGA). 22 January 2020. Archived from the original on 5 September 2021. Retrieved 5 September 2021.
Pettit NN, Carver PL (July 2015). "Isavuconazole: A New Option for the Management of Invasive Fungal Infections". The Annals of Pharmacotherapy. 49 (7): 825–42. doi:10.1177/1060028015581679. PMID 25940222. S2CID 208875031. Archived from the original on 5 September 2021. Retrieved 15 July 2022.